Accuron Technologies plans to further develop its suite of medical devices outsourcing services through its recent acquisition of a majority stake in Aurum Healthcare, a provider of sterilisation services for medical devices and instruments.

"Nantong Jinghua Pharma will become a 78.3% stakeholder in Jiangsu Kingsley Pharmaceuticals."

According to the agreement, Accuron Technologies will place Aurum Healthcare under its Advanced Materials Technologies (AMT) business in order to increase AMT’s manufacturing footprint.

Go deeper with GlobalData

Go deeper with GlobalData

The gold standard of business intelligence.

Find out more

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

Nantong Jinghua Pharma, a Chinese traditional pharma products manufacturer, plans to acquire an additional 29.73% stake in Jiangsu Kingsley Pharmaceuticals.

Following the transaction, Nantong Jinghua Pharma will become a 78.3% stakeholder in Jiangsu Kingsley Pharmaceuticals.

Clinical Trials Arena Excellence Awards - The Benefits of Entering

Gain the recognition you deserve! The Clinical Trials Arena Excellence Awards celebrate innovation, leadership, and impact. By entering, you showcase your achievements, elevate your industry profile, and position yourself among top leaders driving clinical trials industry advancements. Don’t miss your chance to stand out—submit your entry today!

Nominate Now